SALT LAKE CITY–(BUSINESS WIRE)–Eyebot and The Framery at 1-800 Contacts today announced a new partnership kicking off in The Framery’s hometown of Salt Lake City, Utah. Beginning June 3, Eyebot Kiosks will be open at Layton Hills Mall in Layton, Utah…
Category: Business
Phosio Raises $4 Million Seed Round to Bring Affordable AR/AI Glasses to Mass Market
CORVALLIS, Ore.–(BUSINESS WIRE)–Phosio raised $4M to advance lightweight AR glasses with integrated displays using its proprietary thin-film platform and advanced materials.
TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep® in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed
CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–TearSolutions, Inc. (“TearSolutions”), a clinical-stage biotechnology company developing novel ophthalmic therapeutics, today announced receiving Food and Drug Administration (FDA) Orphan Drug (ODD) and Fast Track…
Ollin Biosciences Announces Upcoming Presentations of 20-week Data from Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration at Clinical Trials at the Summit 2026
AUSTIN, Texas–(BUSINESS WIRE)–Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced that 20-week study completion data from its head-to-head Phase 1b JADE clinic…
Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M…
Samsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Vial Across Europe, to Treat Ophthalmic Conditions
INCHEON, Korea–(BUSINESS WIRE)– #Europe–Samsung Bioepis launches Opuviz (aflibercept) in Europe.
Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)– #AECOS2026–Aurion Biotech, Inc. (“Aurion Biotech”), a commercial-stage regenerative cell therapy company dedicated to restoring vision, today announced that the company will present at the Eye Bank…
Warby Parker Announces Participation in Upcoming 2026 Baird Global Consumer, Technology & Services Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a lifestyle brand focused on vision for all, today announced that the Company will be presenting at the 2026 Baird Global Consumer, Technology & Services Conference on Tuesd…
GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today launched GoodRx Companion, a new $14.99-per-month subscription that brings together free and low-cost generic medications, af…
Ollin Biosciences to Participate in Upcoming Investor Conferences
AUSTIN, Texas–(BUSINESS WIRE)–Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced management will participate in two upcoming investor conferences: 2026 Jeffer…
FGX International Announces New Capsule Collection with Love Island
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, an EssilorLuxottica company and one of the world’s leading over-the-counter eyewear brands, has announced a new partnership with ITV Studios, home of one of the most-watched reality TV series worldw…
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure
ALISO VIEJO, Calif.–(BUSINESS WIRE)– #FLIGHTglaucoma–ViaLase announced the successful completion of the first commercial FLIGHT procedures, marking a new era in interventional glaucoma.
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and Chief Medical Officer and…
National Vision, Inc. Announces Participation in William Blair 46th Annual Growth Stock Conference
DULUTH, Ga.–(BUSINESS WIRE)– #nationalvision–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that the Company is scheduled to present at the William Blair 46th Annual Growth Stock Conference on Wedne…
Lexitas Pharma Services, a Leading Ophthalmology CRO, Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie
DURHAM, N.C.–(BUSINESS WIRE)–Lexitas Pharma Services, a portfolio company of QHP Capital, is pleased to announce the closing of its acquisition of Erie Retina Research—one of the nation’s premier retina research centers led by Dr. David Almeida, MD, …
GenSight Biologics to Hold its Combined General Meeting on May 19, 2026
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharmaceutical company focused on developing and commercializing innovative gene therapies for retinal neurodegene…
LambdaVision and Helogen Partner to Advance Space-Based Biomaterial Manufacturing
WOODBRIDGE, Conn.–(BUSINESS WIRE)–LambdaVision, a pre-clinical-stage biotech advancing on-Earth and microgravity bioprocesses, today announced a strategic partnership with Helogen Corporation to launch a joint orbital manufacturing mission of LambdaV…
Brad Caldwell Appointed CEO of Optivate to Succeed Founder
BONITA SPRINGS, Fla.–(BUSINESS WIRE)–Optivate, a leading provider of specialty-built software and solutions for ophthalmology practices, today announced the appointment of Brad Caldwell as Chief Executive Officer. Abdiel Marin, the company’s Founder …
FGX International Announces Licensing Agreement with Iconic American Brand Wrangler®
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, an EssilorLuxottica company and one of the world’s leading over-the-counter eyewear brands, has announced a new licensing partnership with international denim brand Wrangler. Inspired by rodeo fashi…
National Vision Holdings, Inc. Reports First Quarter 2026 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)– #nationalvision–National Vision, Inc. (NASDAQ: EYE), one of the largest optical retailers in the United States, today reported its first quarter 2026 results.